Laquinimod ameliorates secondary brain inflammation-Reference-Cited by-同舟云学术

Laquinimod ameliorates secondary brain inflammation

Published:2020-02 Issue: Volume:134 Page:104675
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Nedelcu Julia,Reinbach Christin,Riedler Philipp,Brendel Matthias^ORCID,Rominger Axel,Kaye Joel,Behrangi Newshan,Jiangshan Zhan,Schmitz Christoph,Kipp Markus^ORCID

Funder

the Dr. Robert Pfleger Stiftung

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Neurology

Reference53 articles.

1. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases;Aboul-Enein;J. Neuropathol. Exp. Neurol.,2003

2. Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [(1)(8)F]DPA-714;Abourbeh;J. Neurosci.,2012

3. In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis;Airas;J. Nucl. Med.,2015

4. ADAM12 is expressed by astrocytes during experimental demyelination;Baertling;Brain Res.,2010

5. Induction of experimental autoimmune encephalomyelitis in mice and evaluation of the disease-dependent distribution of immune cells in various tissues;Barthelmes;J. Vis. Exp.,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroimmunomodulatory properties of laquinimod;Brain Disorders;2024-03

2. Laquinimod Inhibits Microglial Activation, Astrogliosis, BBB Damage, and Infarction and Improves Neurological Damage after Ischemic Stroke;ACS Chemical Neuroscience;2023-05-10

3. Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis;Frontiers in Behavioral Neuroscience;2023-01-05

4. Recent advances in clinical trials targeting the kynurenine pathway;Pharmacology & Therapeutics;2022-08

5. Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis mice;Journal of Neuroimmunology;2022-06